NASDAQ·US·Drug Manufacturers - General
MRKMRK
0คะแนน
สรุป
ปานกลาง
ความมั่นใจ 89%
$110.95—
Today's session
Upside?
+7.2%
FV $118.95
P/E (TTM)?
15.2
Earnings yield
FCF yield?
4.3%
Mcap $274.03B
ถือ
Fundamental neutral·Technical neutral
What investors notice
Key signs
Plain-language read of the metrics that matter most for this stock.
Strongly positive
5 · 1 · 1
Strengths
- Best-in-class return on equity26%
- High return on invested capital17%
- Gross margin trending up
- ROIC well above cost of capital — value-creating13%
- Analyst consensus heavily Buy-skewed
Risks
- Inconsistent profitability4/10
Watchlist
- Long-term debt rising — monitor leverage
$110.95+35.7%
1Y · period change vs 2025-04-29
Score history (10y)
How quality has trended through cycles.
Verdict bands: 85+ Wonderful · 70 Solid · 55 Average · 40 Risky.
Fair value range
5 of 5 models · trimmed-mean consensus
Consensus FV
$118.95
Upside
+7.2%
Now $110.95
Our FV$118.95
Price$110.95
$19.65$269.00
Open the Fair Value tab to tweak WACC and growth, and to see all five model outputs side-by-side.
10-year financials
Annual revenue, profit, and free cash flow with year-over-year growth overlay.
YoY growth overlaid
Snapshot
At a glance
Top-line figures most investors check first.
Market cap
$274.03B
P/E (TTM)?
15.2
FCF yield?
4.3%
Dividend
$3.24
2.9% yield
52w range
$70.89 – $123.18
Score confidence
89%
Data completeness
Last updated 4/30/2026, 5:20:47 AM · Data via Yahoo Finance, FMP, EDGAR. Disclaimer